吗氯贝胺...
阿拉丙酯西酞普兰依地普仑非莫西汀氟苯氧丙胺氟伏沙明茚达品伊福西汀利托西汀鲁巴唑酮OmiloxetineOmiloxetine帕奴拉明帕罗西汀吡喃达明塞罗西汀舍曲林齐美定氯伏胺去甲文拉法辛度洛西汀左旋体米那普仑依氯那明米那普仑西布曲明文拉法辛AmitifadineAmitifadine比西发定BrasofensineBrasofensineBTS-74,398BTS 74,398可卡因双氮奋兴DOV-21,947DOV-21,947DOV-102,677DOV-102,677DOV-216,303DOV-216,303EXP-561EXP-561非唑拉明JNJ-7925476JNJ-7925476NS-2359NS-2359PRC200-SSPRC200-SSPridefinePridefineSEP-225,289SEP-225289SEP-227,162TesofensineTesofensine氨甲达林阿托莫西汀苯奈达林氢苯嘧吲哚达来达林EdivoxetineEdivoxetine恶泼西汀氯他拉明吗吲哚尼索西汀瑞波西汀他洛普仑他舒普仑坦达明维洛沙秦美地沙明伐诺司林阿米庚酸安非他酮西洛巴明ManifaxineManifaxine哌甲酯诺米芬辛RadafaxineRadafaxine他美曲林苯丙胺苯呋拉林二甲磺酸赖右苯丙胺甲基苯丙胺苯乙胺吡贝拉林反苯环丙胺4-Methyl-αMT4-Methyl-AMTαET/Etryptaminealpha-EthyltryptamineαMT/Metryptaminealpha-MethyltryptamineTianeptineTianeptineIndeloxazineIndeloxazineTeniloxazineTeniloxazine曲马多ViqualineViqualineTiazesimTiazesimTofenacinTofenacinAmezepineAmezepineAmineptineAmineptine阿米替林AmitriptylinoxideAmitriptylinoxideAzepindoleAzepindoleButriptylineButriptylineCianopramineCianopramine氯米帕明CotriptylineCotriptylineCyanodothiepinCyanodothiepinDemexiptilineDemexiptilineDepramineDepramineBalipramineBalipramineDesipramineDesipramineDibenzepinDibenzepinDimetacrineDimetacrineDosulepin/DothiepinDosulepinDoxepinDoxepinEnprazepineEnprazepineFluotracenFluotracenHepzidineHepzidineHomopipramolHomopipramolImipramineImipramineImipraminoxideImipraminoxideIntriptylineIntriptylineIprindoleIprindoleKetipramineKetipramineLitracenLitracenLofepramineLofepramineLosindoleLosindoleMariptilineMariptilineMelitracenMelitracenMetapramineMetapramineMezepineMezepineNaranolNaranolNitroxazepineNitroxazepineNortriptylineNortriptylineNoxiptilineNoxiptilineOctriptylineOctriptylineOpipramolOpipramolPipofezinePipofezinePropizepinePropizepineProtriptylineProtriptylineQuinupramineQuinupramineTampramineTampramineTianeptineTianeptineTienopramineTienopramineTrimipramineTrimipramineAmoxapineAmoxapineAptazapineAptazapineAzipramineAzipramineCiclazindolCiclazindolCiclopramineCiclopramineEsmirtazapineEsmirtazapineMaprotilineMaprotilineMazindolMazindol米塞林米氮平OxaprotilineOxaprotilineSetiptiline/TeciptilineSetiptiline阿奈螺酮阿立哌唑贝非拉醇丁螺环酮依他匹隆氟辛克生氟立班丝氨吉哌隆伊沙匹隆奥沙氟生坦度螺酮维拉佐酮扎螺酮世卫基本药物(WHO-EM)撤回臨床試驗第三階段未到第三階段Mixed amphetamine saltsAdderallAdderall XR可乐定GuanfacineGuanfacine金刚烷胺卡马西平MemantineMemantine
抗抑郁药物单胺氧化酶抑制剂氯代芳烴苯酰胺类吗啉
美国英国澳大利亚罗氏南非酪胺抗胆碱剂医学导航心理学精神病学心理历程障碍opmpads症状齐名涉及评估治疗N5A5B5C6A6B6D
body.skin-minerva .mw-parser-output table.infobox caption{text-align:center}
系统(IUPAC)命名名称 | |
---|---|
4-chloro-N-(2-morpholin-4-ylethyl)benzamide | |
临床数据 | |
商品名 | Amira, Aurorix, Clobemix, Depnil, Manerix |
Drugs.com | Micromedex详细消费者药物信息 |
妊娠分级 |
|
给药途径 | oral |
合法狀態 | |
合法状态 |
|
药代动力学数据 | |
生物利用度 | 55-95% (increases with repeat administration)[1] |
蛋白结合度 | 50%[2] |
代谢 | Hepatic |
生物半衰期 | 1-2 hours, 4 hours (elderly)[3][4] |
排泄 | Renal, Faecal (<5%)[2] |
识别信息 | |
CAS注册号 | 71320-77-9 |
ATC代码 | N06AG02 |
PubChem | CID 4235 |
IUPHAR/BPS | 7428 |
DrugBank | DB01171 |
ChemSpider | 4087 |
UNII | PJ0Y7AZB63 |
KEGG | D02561 |
ChEBI | CHEBI:83531 |
ChEMBL | CHEMBL86304 |
化学信息 | |
化学式 | C13H17ClN2O2 |
摩尔质量 | 268.739 g/mol |
SMILES
| |
InChI
| |
(what is this?) (verify) |
吗氯贝胺(商品名也作Amira、Aurorix、[5]Clobemix、Depnil或Manerix)是主要用于治疗抑郁症和社交焦虑的单胺氧化酶A(RIMA)药物的可逆抑制剂。[6]它在美国不被允许使用,但在其它西方国家,例如英国和澳大利亚(TGA于2000年12月)是被批准使用的。[7]它由罗氏公司的附属公司生产。起初,Aurorix也在南非由罗氏公司供应,但在专利期满之后撤回,Cipla Medpro's Depnil和Pharma Dynamic's Clorix的成本减半。
当吗氯贝胺与胺类混用时,如含酪胺的食物或升压胺类药物,不会出现显著的血压升高,这与较老的非选择性和不可逆单胺氧化酶抑制剂(MAOI)不同,后者的混用会导致血压严重上升。由于不会造成抗胆碱剂、心血管、认知与精神运动损伤,吗氯贝胺在老年人以及心血管疾病患者中是有利的。[6]
参考文献
^ Fitton, A; Faulds, D; Goa, KL. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness. Drugs. April 1992, 43 (4): 561–596. PMID 1377119. doi:10.2165/00003495-199243040-00009.
^ 2.02.1 Schoerlin, MP; Mayersohn, M; Korn, A; Eggers, H. Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjects. Clinical Pharmacology and Therapeutics. October 1987, 42 (4): 395–404. PMID 3665338.
^ Freeman, H. Moclobemide. Lancet. December 1993, 342 (8886-8887): 1528–1532. PMID 7902906. doi:10.1016/S0140-6736(05)80090-X.
^ Gex-Fabry, M; Balant-Gorgia, AE; Balant, LP. Potential of concentration monitoring data for a short half-life drug: analysis of pharmacokinetic variability for moclobemide. Therapeutic Drug Monitoring. February 1995, 17 (1): 39–46. PMID 7725375. doi:10.1097/00007691-199502000-00007.
^ Scheen AJ. [Drug of the month. Moclobemide (Aurorix)]. Rev Med Liege. May 1994, 49 (5): 291–2. PMID 8023056 (法语).
^ 6.06.1 Fulton B, Benfield P. Moclobemide. An update of its pharmacological properties and therapeutic use. Drugs. September 1996, 52 (3): 450–74. PMID 8875133. doi:10.2165/00003495-199652030-00013.
^ PRODUCT INFORMATION MOCLOBEMIDE SANDOZ® 150mg and 300mg TABLETS. TGA eBusiness Services. Sandoz. 6 March 2012 [16 October 2013].
拓展阅读
- Scientific Information on Aurorix (German)
PubChem Substance Summary: Moclobemide National Center for Biotechnology Information.
|
|